ReShape Lifesciences【RSLS】銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

3.845

買値

3.59

売値

3.95

出来高

50,814

3.50 日の範囲 3.94

3.61 52 週間の範囲 29.00

時価総額

2.74M

前日終値

3.65

始値

3.80

時刻

3.81

最終取引時間

06:00:00

財務取引量

US$ 190,151

VWAP

3.7421

平均取引量 (3 か月)

57,706

発行済株式数

712,680

配当利回り

PER

-0.24

1 株当たり利益 (EPS)

-15.98

歳入

8.68M

純利益

-11.39M

Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, a... Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, and ReShapeCare, a virtual coaching program delivered through an app. 詳細を表示

セクター

Surgical,med Instr,apparatus

業界

Surgical,med Instr,apparatus

ウェブサイト

www.reshapelifesciences.com

本社

Wilmington, Delaware, USA

設立

ReShape Lifesciences Inc is listed in the Surgical,med Instr,apparatus sector of the ナスダック市場 with ticker RSLS. The last closing price for ReShape Lifesciences was US$3.65. Over the last year, ReShape Lifesciences shares have traded in a share price range of US$ 3.61 to US$ 29.00.

ReShape Lifesciences currently has 712,680 shares in issue. The market capitalisation of ReShape Lifesciences is US$2.60 million. ReShape Lifesciences has a price to earnings ratio (PE ratio) of -0.24.

Form 8-K - Current report

Form S-1 - General form for registration of securities under the Securities Act of 1933

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

ReShape Lifesciences® Provides Update on Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys

IRVINE, Calif. and CAMBRIDGE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, and...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.685	-15.1214128035	4.53	4.53	3.61	22011	4.07501898	CS
4	-0.645	-14.3652561247	4.49	5.19	3.61	25437	4.62768056	CS
12	-2.025	-34.4974446337	5.87	6.04	3.61	57706	5.32586995	CS
26	-7.8536	-67.1328193117	11.6986	12.4584	3.61	289500	8.11320845	CS
52	-8.335	-68.4318555008	12.18	29	3.61	1848791	13.64285508	CS
156	-3389.155	-99.8866784556	3393	4466	3.61	1515962	137.20399563	CS
260	-749.285	-99.4894639704	753.13	27550	3.61	1401529	3159.4391471	CS

RSLS - Frequently Asked Questions (FAQ)

What is the current ReShape Lifesciences share price?

The current share price of ReShape Lifesciences is US$ 3.845

How many ReShape Lifesciences shares are in issue?

ReShape Lifesciences has 712,680 shares in issue

What is the market cap of ReShape Lifesciences?

The market capitalisation of ReShape Lifesciences is USD 2.6M

What is the 1 year trading range for ReShape Lifesciences share price?

ReShape Lifesciences has traded in the range of US$ 3.61 to US$ 29.00 during the past year

What is the PE ratio of ReShape Lifesciences?

The price to earnings ratio of ReShape Lifesciences is -0.24

What is the cash to sales ratio of ReShape Lifesciences?

The cash to sales ratio of ReShape Lifesciences is 0.32

What is the reporting currency for ReShape Lifesciences?

ReShape Lifesciences reports financial results in USD

What is the latest annual turnover for ReShape Lifesciences?

The latest annual turnover of ReShape Lifesciences is USD 8.68M

What is the latest annual profit for ReShape Lifesciences?

The latest annual profit of ReShape Lifesciences is USD -11.39M

What is the registered address of ReShape Lifesciences?

The registered address for ReShape Lifesciences is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the ReShape Lifesciences website address?

The website address for ReShape Lifesciences is www.reshapelifesciences.com

Which industry sector does ReShape Lifesciences operate in?

ReShape Lifesciences operates in the SURGICAL,MED INSTR,APPARATUS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
OSTOstin Technology Group Company Ltd	US$ 3.89 (32.76%)	1.34M
PCSAProcessa Pharmaceuticals Inc	US$ 0.7781 (31.37%)	1.47M
CARMCarisma Therapeutics Inc	US$ 0.61 (20.86%)	3.93M
ASSTAsset Entities Inc	US$ 0.9499 (15.14%)	156.95k
IVAInventiva SA	US$ 2.62 (13.91%)	19.87k
CRGXCARGO Therapeutics Inc	US$ 3.84 (-70.89%)	699.8k
FIBKFirst Interstate BancSystem Inc	US$ 27.25 (-17.07%)	8.49k
DGNXDiginex Ltd	US$ 42.2417 (-15.77%)	118.98k
MXLMaxLinear Inc	US$ 18.59 (-14.69%)	74.4k
IKTInhibikase Therapeutics Inc	US$ 2.39 (-14.64%)	232.77k
NVDANVIDIA Corporation	US$ 125.77 (1.67%)	28.71M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 26.43 (6.87%)	14.41M
TSLATesla Inc	US$ 402.5392 (3.45%)	10.25M
VCSHVanguard Short Term Corporate Bond	US$ 78.41 (0.00%)	9.57M
MGOLMGO Global Inc	US$ 0.1143 (12.39%)	6.04M